INIS
abundance
66%
bile ducts
44%
biology
11%
cancer
11%
chains
11%
comparative evaluations
22%
control
33%
diseases
100%
epithelium
11%
hepatomas
33%
levels
11%
lipids
22%
liver
33%
malignancies
11%
mass spectrometry
22%
metastases
22%
patients
44%
tissues
44%
tumors
100%
variations
11%
Keyphrases
Between-group
6%
Bile Duct
18%
Bile Duct Epithelium
6%
Cancer Types
6%
Cholangiocarcinoma
6%
Clinical Outcomes
12%
Colorectal Liver Metastases
12%
Comparisons with a Control
6%
Control Tissue
6%
Disease-free Survival
100%
Early Tumor Recurrence
6%
Hepatocellular Carcinoma
12%
Hepatocellular Carcinoma Tissues
6%
High Ratio
12%
Intrahepatic Cholangiocarcinoma (iCCA)
100%
Lipid Component
6%
Lipid Rafts
6%
Liver
6%
Malignancy
6%
Mass Spectrometry Imaging
12%
Overall Survival
6%
Poor Outcome
6%
Relative Abundance
6%
Relative Amount
6%
Structural Class
6%
Sulfatide
100%
Tumor
100%
Tumor Area
6%
Tumor Biology
6%
Tumor Samples
6%
Tumor Tissue
12%
Pharmacology, Toxicology and Pharmaceutical Science
Bile Duct Carcinoma
100%
Colorectal Liver Metastasis
12%
Disease Free Survival
100%
Liver Cell Carcinoma
18%
Malignant Neoplasm
6%
Neoplasm
100%
Overall Survival
6%
Sulfatide
100%
Tumor Recurrence
6%